Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 02, 2023

SELL
$1.19 - $2.09 $2,177 - $3,824
-1,830 Reduced 15.15%
10,246 $13,000
Q3 2022

Nov 09, 2022

BUY
$1.81 - $2.76 $260 - $397
144 Added 1.21%
12,076 $23,000
Q2 2022

Aug 15, 2022

BUY
$1.34 - $5.34 $1,181 - $4,709
882 Added 7.98%
11,932 $25,000
Q1 2022

Jun 30, 2022

SELL
$4.58 - $6.8 $4,030 - $5,984
-880 Reduced 7.38%
11,050 $51,000
Q4 2021

Feb 15, 2022

SELL
$5.23 - $7.18 $1,814 - $2,491
-347 Reduced 2.83%
11,930 $77,000
Q3 2021

Oct 29, 2021

SELL
$5.94 - $8.75 $3,059 - $4,506
-515 Reduced 4.03%
12,277 $76,000
Q2 2021

Aug 16, 2021

BUY
$7.54 - $9.79 $96,451 - $125,233
12,792 New
12,792 $102,000

Others Institutions Holding CMRX

About CHIMERIX INC


  • Ticker CMRX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 87,622,896
  • Market Cap $77.1M
  • Description
  • Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...
More about CMRX
Track This Portfolio

Track Amalgamated Bank Portfolio

Follow Amalgamated Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amalgamated Bank, based on Form 13F filings with the SEC.

News

Stay updated on Amalgamated Bank with notifications on news.